Hubei Goto Biopharm Co.,Ltd. (SHE:300966)
China · Delayed Price · Currency is CNY 19.21
-0.29 (-1.49%)
Jul 18, 2025, 10:44 AM CST
Hubei Goto Biopharm Market Cap
Hubei Goto Biopharm has a market cap or net worth of 2.25 billion as of July 17, 2025. Its market cap has increased by 16.42% in one year.
Market Cap
2.25B
Enterprise Value
3.42B
Revenue
553.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.21
Market Cap Chart
Since April 9, 2021, Hubei Goto Biopharm's market cap has decreased from 6.57B to 2.25B, a decrease of -65.78%. That is a compound annual growth rate of -22.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 2.25B | 20.89% |
| Dec 31, 2024 | 1.86B | -29.78% |
| Dec 29, 2023 | 2.65B | -14.93% |
| Dec 30, 2022 | 3.11B | -34.18% |
| Dec 31, 2021 | 4.73B | -28.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 382.31B |
| Shenzhen Mindray Bio-Medical Electronics | 262.44B |
| WuXi AppTec | 224.70B |
| Zhangzhou Pientzehuang Pharmaceutical., | 119.33B |
| Aier Eye Hospital Group | 114.99B |
| Sichuan Biokin Pharmaceutical | 113.84B |
| Shanghai United Imaging Healthcare | 102.37B |
| Yunnan Baiyao Group Co.,Ltd | 99.90B |